Alys Pharmaceuticals Funding & Investors
Alys Pharmaceuticals engages in immuno-dermatology services. The company is reshaping the treatment landscape through advanced scientific innovations and a strong research and development-focused multi-platform pipeline. Alys emerged as a result of the strategic aggregation of 6 asset-centric companies backed by Medicxi.
alyspharma.comTotal Amount Raised: $100,000,000
Alys Pharmaceuticals Funding Rounds
Seed
$100,000,000
Seed Investors
Medicxi
Funding info provided by Diffbot.